Vytorin(R) (ezetimibe/simvastatin) Versus Zocor(R) (simvastatin) For Patients With High Cholesterol, Data Analysis
In a new analysis presented today VYTORIN(R) (ezetimibe/simvastatin) significantly reduced LDL “bad” cholesterol by an average of 52.5 percent and C-reactive protein (CRP) by an average of 31.0 percent, compared to averages of 38.0 percent and 14.3 percent, respectively, achieved with Zocor(R) (simvastatin) (p